Trials / Enrolling By Invitation
Enrolling By InvitationNCT06113315
A Study Involving Collection of Samples and Data From Sarcoma Patients Receiving Immunotherapy
An Observational Study of Sarcoma Patients Treated With Immunotherapy at Memorial Sloan Kettering Cancer Center
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (estimated)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The researchers are doing this study to improve their knowledge about immunotherapy use and how effective it is as a treatment for people with sarcoma by collecting information from participants' medical records who have been treated with immune checkpoint blockade or T-cell receptor-based therapy.
Conditions
Timeline
- Start date
- 2023-10-27
- Primary completion
- 2028-10-01
- Completion
- 2028-10-01
- First posted
- 2023-11-02
- Last updated
- 2025-10-27
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06113315. Inclusion in this directory is not an endorsement.